Affiliation: San Raffaele Scientific Institute
- Clinical predictors of drug response in obsessive-compulsive disorderS Erzegovesi
Department of Neuropsychiatric Sciences, S Raffaele Hospital, University of Milan School of Medicine, Milano, Italy
J Clin Psychopharmacol 21:488-92. 2001....
- Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled studyStefano Erzegovesi
Department of Neurosciences, San Raffaele Hospital, Vita Salute San Raffaele University, Via Stamira d Ancona 20, 20127 Milan, Italy
Eur Neuropsychopharmacol 15:69-74. 2005..This preliminary study suggests that even very low (0.5 mg) risperidone doses are effective in OC patients who were nonresponders to a standardized treatment with fluvoxamine...
- Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depressionL Bellodi
Department of Neuropsychiatric Sciences, Istituto Scientifico Ospedale San Raffaele, University of Milan School of Medicine, Italy
Psychiatry Res 69:9-15. 1997..Our data suggest that a major depressive syndrome could be a state variable affecting the changes in plasma TRP and TRP/LNAA ratio in OCD patients...
- Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment responseD Di Bella
Fondazione Centro San Raffaele del Monte Tabor, San Raffaele Vita Salute University, Department of Neuropsychiatric Sciences, Milan, Italy
Pharmacogenomics J 2:176-81. 2002..Considering patients without tic disorder co-diagnosis, a significant time per genotype interaction for both YBOCS total scores and compulsion scores was found...